admin @ Mon, 2005-10-24 21:46
The costs of the flu and pneumococcal vaccines are $25 and $35, respectively. Patients with Medicare Part B may receive the vaccines at no cost. In addition, Medicare recipients will be provided with valuable materials at all flu clinics regarding the Medicare Part D Prescription Drug Plan.
In Massachusetts and Georgia, many Brooks and Eckerd pharmacists will be administering flu vaccines, as well. These pharmacists, entitled "Certified Immunizers," have successfully completed the APhA Immunization Training Program. The Brooks and Eckerd Certified Immunizers plan to administer 12,000 flu shots for the 2005 flu season.
"The convenience of a retail pharmacy and the healthcare expertise of our community pharmacists will lead us to expand this program in the future" explained Dan Haron, Senior Vice President of Pharmacy at Brooks Eckerd Pharmacy.
Brooks Eckerd Pharmacy will be conducting nearly 2,000 clinics this fall and anticipates serving approximately 150,000 patients. More information, including the specific schedule, can be found at brooksrx.com and eckerd.com.
The Jean Coutu Group (PJC) Inc. is the fourth largest drugstore chain in North America and the second largest in both the eastern United States and Canada. The Company and its combined network of 2,172 corporate and franchised drugstores (under the banners of Brooks and Eckerd Pharmacy, PJC Jean Coutu, PJC Clinique and PJC Sante Beaute) employ more than 60,000 people.
The Jean Coutu Group's United States operations employ 46,000 people and comprise 1,851 corporate owned stores located in 18 states of the Northeastern, mid-Atlantic and Southeastern United States. The Jean Coutu Group's Canadian operations and franchised drugstores in its network employ over 14,000 people and comprise 321 PJC Jean Coutu franchised stores in Quebec, New Brunswick and Ontario.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The words "looking forward," "looking ahead," "believe(s)," "should," "may," "expect(s)," "anticipate(s)," "likely," "opportunity," and similar expressions, among others, identify forward-looking statements. The Company undertakes no obligation to update any forward-looking statements contained in this press release.
This is cache, read story here